FRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ — AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices, todayFRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ — AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices, today

AllyGPO and BioCareSD Welcome Retina Associates of Cleveland, Highlighting the Market Need for New Transparent, Technology-Forward Options

FRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ — AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices, today announced that Retina Associates of Cleveland, Inc (RACI) has selected BioCareSD for specialty distribution (SD) and AllyGPO for group purchasing organization (GPO) services. This relationship expands AllyGPO and BioCareSD’s growing national footprint in community retina and reflects increasing demand for alternative GPO and SD options that offer more transparent, technology-enabled drug management.

Founded in 1974 and celebrating more than 50 years of patient care, RACI is widely regarded as one of Ohio’s premier retina specialty practices. The practice is known for its leadership in clinical research and expertise in advanced treatments for age-related macular degeneration, diabetic retinopathy, retinal tears and detachments, and other complex retinal conditions.

“Maintaining our independence is central to how RACI cares for patients, and we value partners who support this,” said President of RACI David G. Miller, MD. “BioCareSD and AllyGPO, through consistent actions and collaboration, have demonstrated their genuine commitment to preserving community retina practice independence in meaningful, practical ways. Choosing to partner with them enables RACI to better manage day-to-day operational and financial demands while securing long-term resilience with more efficient workflows and greater visibility from data-driven analytics.”

AllyGPO and BioCareSD provide RACI with high-touch specialty distribution and GPO services designed specifically for modern community retina practices. Key considerations in RACI’s decision included supply reliability, transparency in drug pricing, more timely, accurate GPO contract rebates, and responsive, consultative support from a dedicated retina team that works closely with clinical and administrative teams.

Another differentiator was AllyGPO and BioCareSD’s technology-forward approach, including AllyIQ®, AllyGPO’s comprehensive specialty drug management platform. By integrating data from practices’ core operational systems and BioCareSD’s ordering site, AllyIQ supports informed decision making with clear, actionable insights into purchasing, inventory, and utilization.

“RACI exemplifies the kind of physician-led practice that AllyGPO was built to serve,” remarked Brian Ansay, CEO of AllyGPO. “Our role as a GPO is to provide insight and hands-on support that helps members navigate complexity, confidently make data-driven decisions, and firmly remain in control of their future.”

“Retina Associates of Cleveland is a highly respected practice with a longstanding reputation for clinical excellence and physician leadership,” said Jennifer Waters, SVP of Retina at BioCareSD. “Their decision to partner with us reinforces that the market is seeking more transparent, flexible, and technology-enabled distribution and GPO partners built specifically around the needs of community retina practices.” 

The addition of RACI reflects AllyGPO and BioCareSD’s continued growth in community retina, as practices seek support in navigating rising drug costs, payer pressures, new biosimilar introductions, increasing administrative complexity, and distributors’ acquisition of practices. To learn more, visit www.NewRetinaPartner.com.

About Retina Associates of Cleveland, Inc.
Retina Associates of Cleveland, Inc (RACI) is the largest retina practice in Ohio. Since 1974, the practice has striven to improve the quality of life for every patient by preserving their best vision possible. With 17 retinal specialists, 13 northeast Ohio locations, and continual clinical trials, the community has access to world-renowned expert retinal care.

About AllyGPO
AllyGPO is a tech-forward group purchasing organization empowering community practices to operate more efficiently, improve practice economics, and remain independent through AllyRetina, its dedicated retina service, and AllyIQ®, its comprehensive drug management platform combining inventory management, GPO contract optimization, and advanced analytics. www.AllyGPO.com.

About BioCareSD
BioCareSD, a BioCare company, is a national specialty distributor with over 40 years of experience delivering life-changing specialty therapies. Committed to redefining specialty distribution, BioCareSD focuses on trust, transparency, and operational excellence. The company provides high-touch, personalized service through a dedicated support team and 24/7/365 customer care. Its distribution model and expanding portfolio support partners in delivering care. www.biocaresd.com.

Media Contact:
Dara Shulman
[email protected]
866-255-9476

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allygpo-and-biocaresd-welcome-retina-associates-of-cleveland-highlighting-the-market-need-for-new-transparent-technology-forward-options-302663422.html

SOURCE AllyGPO and BioCareSD

Market Opportunity
Stader Logo
Stader Price(SD)
$0.2349
$0.2349$0.2349
-0.67%
USD
Stader (SD) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Robinhood’s New Move: MNT Coin Joins the Roster

Robinhood’s New Move: MNT Coin Joins the Roster

Bitcoin continues to hover beneath the $91,000 threshold, but the crypto domain isn’t stagnating. Cryptocurrency platforms are vigorously expanding their altcoin
Share
Coinstats2026/01/20 21:48
Robinhood Crypto has listed the MNT token.

Robinhood Crypto has listed the MNT token.

PANews reported on January 20 that Robinhood announced on its X platform that the MNT token is now available for trading on Robinhood Crypto, including in the New
Share
PANews2026/01/20 22:02
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56